LeMaitre to Present at the Needham Virtual Growth Conference

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced that CFO JJ Pellegrino will present at the 24th Annual Needham Virtual Growth Conference on January 14, 2022, at 3:30 PM.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced that CFO JJ Pellegrino will present at the 24th Annual Needham Virtual Growth Conference on January 14, 2022, at 3:30 PM. The company specializes in devices and services for treating peripheral vascular disease, which affects over 200 million people globally. LeMaitre develops a range of disposable and implantable vascular devices aimed at meeting the needs of vascular surgeons. Additional details are available on their website at www.lemaitre.com.

Argus Session date unavailable

-0.27% session move Open Argus

Details

News Market Reaction – LMAT

The recorded move for LMAT in the trading session of this news was -0.27%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

12/30/2021 - 11:24 AM

BURLINGTON, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 24th Annual Needham Virtual Growth Conference on Friday, January 14, 2022, at 3:30 PM.

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date of LeMaitre Vascular's presentation at the Needham Conference?

LeMaitre Vascular's presentation is on January 14, 2022.

Who will represent LeMaitre Vascular at the Needham Conference?

JJ Pellegrino, the Chief Financial Officer, will represent LeMaitre Vascular.

What time is LeMaitre Vascular's presentation scheduled for?

The presentation is scheduled for 3:30 PM.

What does LeMaitre Vascular specialize in?

LeMaitre Vascular specializes in devices and services for peripheral vascular disease.

How many people are affected by peripheral vascular disease worldwide?

Peripheral vascular disease affects more than 200 million people worldwide.

Keep reading

Trending in the feed

AMTM

Amentum Joint Venture Secures Preferred Position for Major UK Nuclear Contract Open the live feed